Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: There is evidence that natural killer (NK) cells help control persistent viral infections including hepatitis C virus (HCV). The phenotype and function of blood and intrahepatic NK cells, in steady state and after interferon (IFN) α treatment has not been fully elucidated. DESIGN: We performed a comparison of NK cells derived from blood and intrahepatic compartments in multiple paired samples from patients with a variety of chronic liver diseases. Furthermore, we obtained serial paired samples from an average of five time points in HCV patients treated with IFNα. RESULTS: Liver NK cells demonstrate a distinct activated phenotype compared to blood manifested as downregulation of the NK cell activation receptors CD16, NKG2D, and NKp30; with increased spontaneous degranulation and IFN production. In contrast, NKp46 expression was not downregulated. Indeed, NKp46-rich NK populations were the most activated, correlating closely with the severity of liver inflammation. Following initiation of IFNα treatment there was a significant increase in the proportion of intrahepatic NK cells at days 1 and 3. NKp46-rich NK populations demonstrated no reserve activation capacity with IFNα treatment and were associated with poor viral control on treatment and treatment failure. CONCLUSIONS: NKp46 marks out pathologically activated NK cells, which may result from a loss of homeostatic control of activating receptor expression in HCV. Paradoxically these pathological NK cells do not appear to be involved in viral control in IFNα-treated individuals and, indeed, predict slower rates of viral clearance.

Original publication

DOI

10.1136/gutjnl-2013-304472

Type

Journal article

Journal

Gut

Publication Date

03/2014

Volume

63

Pages

515 - 524

Keywords

CHRONIC VIRAL HEPATITIS, HEPATITIS C, IMMUNE-MEDIATED LIVER DAMAGE, IMMUNOLOGY IN HEPATOLOGY, Adult, Aged, Antiviral Agents, Biomarkers, Biopsy, Case-Control Studies, Drug Administration Schedule, Drug Resistance, Viral, Drug Therapy, Combination, Female, Flow Cytometry, Hepatic Insufficiency, Hepatitis C, Chronic, Humans, Immunohistochemistry, Interferon-alpha, Killer Cells, Natural, Linear Models, Liver, Lymphocyte Activation, Male, Middle Aged, Natural Cytotoxicity Triggering Receptor 1, Ribavirin, Severity of Illness Index, Treatment Failure, Viral Load